News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

New Institute of Medicine Report Finds Diagnostic Errors Continue to Put Americans at Risk

Pathologists and clinical laboratories could help reduce error rate through greater collaboration with providers

Expect the topic of diagnostic mistakes to get more media attention in coming years. That is consistent with the efforts of healthcare policymakers to improve patient safety while making it easier for consumers to access information about the quality and cost when selecting hospitals, physicians, and medical laboratories.

One opening salvo in this campaign is a new report from the Institute of Medicine (IOM) titled “Improving Diagnosis in Health Care.” It concludes that Americans will receive at least one wrong or late diagnosis in their lifetime. The rate of diagnostic errors is a patient-safety issue in which pathologists and clinical laboratories could play an important role in reducing.

Pathologists often know which physicians in their community routinely order inappropriate or wrong tests for patients. That is why pathologists could be instrumental in reducing diagnostic errors through better communication with providers to ensure doctors not only order the correct clinical laboratory tests, but also select the appropriate therapies based on test results. (more…)

Major Biobanking Center Planned for Kannapolis, North Carolina, in Tandem with a Multi-Decade Study of the Role of Genetics in Chronic Disease

Pathologists and clinical laboratory scientists may see this research initiative—dubbed the MURDOCK Study—produce knowledge that results in new diagnostic medical lab tests

Can molecular biomarkers do for a North Carolina town what silicon chips did for California’s Silicon Valley? At least one city in the Tar Heel State hopes that it can develop into a major hub for research, development, and the commercialization of molecular science and next-generation gene sequencing.

The unlikely contender pursuing this goal is the city of Kannapolis. With a population of 43,000 and located about 25 miles northwest of Charlotte, the city fathers of Kannopolis appear to be positioning the community as an up-and-coming global center for biobanking. (more…)

;